Clinical Trial Biorepository & Archiving Solutions Market Size Hit 10.1 Bn by 2030

SHARE THIS ARTICLE

The global Clinical Trial Biorepository & Archiving Solutions market size is expected to be worth around US$ 10.1 billion by 2030, according to a new report by Vision Research Reports.

The global Clinical Trial Biorepository & Archiving Solutions market size was valued at US$ 5.1 billion in 2020 and is anticipated to grow at a CAGR of 15.2% during forecast period 2021 to 2030.

Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchreports.com/report/sample/38472

Clinical Trial Biorepository & Archiving Solutions Market (By Service: Biorepository Services, Archiving Solution Services; By Product: Preclinical Products, Clinical Products) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Clinical Trial Biorepository & Archiving Solutions Market Size 2021 to 2030

Key Players

  • Brooks Life Science
  • Patheon
  • Precision for Medicine, Inc.
  • Medpace
  • LabCorp Drug Development
  • ATCC
  • Q2 Solutions
  • Labconnect
  • Charles River Laboratories
  • Cell&Co
Report Coverage Details
Market Size US$ 10.1 billion by 2030
Growth Rate CAGR of 15.2% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Service, Product, Phase
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Brooks Life Science; Patheon; Precision for Medicine, Inc.; Medpace; LabCorp Drug Development; ATCC; Q2 Solutions; Labconnect; Charles River Laboratories; Cell&Co

Market Segmentation

  • Service
    • Biorepository Services
      • Warehousing & Storage
      • Transportation
      • Sample Processing
      • Others
    • Archiving Solution Services
      • Database Indexing and Management
      • Scanning & Destruction
  • Product
    • Preclinical Products
    • Clinical Products
      • Human Tissue
      • Organs
      • Stem Cells
      • Other Biospecimens
  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Clinical Trial Biorepository & Archiving Solutions Market, By Service

7.1.  Clinical Trial Biorepository & Archiving Solutions Market, by Service, 2021-2030

7.1.1.    Biorepository Services

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Archiving Solution Services

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Clinical Trial Biorepository & Archiving Solutions Market, By Product

8.1.  Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2021-2030

8.1.1.    Preclinical Products

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Clinical Products

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Clinical Trial Biorepository & Archiving Solutions Market, By Phase

9.1.  Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2021-2030

9.1.1.    Phase I

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Phase II

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Phase III

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Phase IV

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Clinical Trial Biorepository & Archiving Solutions Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Service (2017-2030)

10.1.2.  Market Revenue and Forecast, by Product (2017-2030)

10.1.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Service (2017-2030)

10.2.2.  Market Revenue and Forecast, by Product (2017-2030)

10.2.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Service (2017-2030)

10.3.2.  Market Revenue and Forecast, by Product (2017-2030)

10.3.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Service (2017-2030)

10.4.2.  Market Revenue and Forecast, by Product (2017-2030)

10.4.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Service (2017-2030)

10.5.2.  Market Revenue and Forecast, by Product (2017-2030)

10.5.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

Chapter 11.  Company Profiles

11.1.              Brooks Life Science

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Patheon

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Precision for Medicine, Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Medpace

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              LabCorp Drug Development

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              ATCC

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Q2 Solutions

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Labconnect

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Charles River Laboratories

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Cell&Co

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38472 or call: +1 9197 992 333

Daksh

Daksh is an SEO Analyst having 3 years of experienced. we can quickly understand and support initiatives that will contribute to the goals and success of client campaigns. and also Perform keyword research in coordination with client business objectives to optimize existing content and uncover new opportunities.

View all posts by Daksh →

Leave a Reply

Your email address will not be published. Required fields are marked *